首页> 外国专利> CORRELATION OF RATIO OF TP TO DPDmRNA EXPRESSION LEVEL IN COLORECTAL CANCER WITH DISEASE-FREE SURVIVAL RATIO IN 5-FU TREATED PATIENT

CORRELATION OF RATIO OF TP TO DPDmRNA EXPRESSION LEVEL IN COLORECTAL CANCER WITH DISEASE-FREE SURVIVAL RATIO IN 5-FU TREATED PATIENT

机译:5 FU治疗患者大肠癌中TP比例与DPDmRNA表达水平的相关性与无病生存率的相关性

摘要

PPROBLEM TO BE SOLVED: To provide a method for identifying a parameter indicative for susceptibility to 5-fluoro-uracil (5-FU) and/or a 5-FU analogue in all potential parameters suggested in the prior art, and for determining under what conditions the parameter provides the highest possible specificity. PSOLUTION: The method for determining whether a patient suffering from cancer is susceptible to a treatment with the 5-FU and/or the 5-FU analogue comprises (a) determination of tymidine phosphorylase (TP) mRA expression in a clinical sample, (b) determination of diphydropyrimidine dehydrogenase (DPD) mRNA expression in the clinical sample, (c) determination of the ratio of the value obtained in step (a) to the value obtained in step (b), and (d) whether the ratio obtained in step (c) exceeds a predetermined cut off value. PCOPYRIGHT: (C)2005,JPO&NCIPI
机译:

要解决的问题:提供一种方法,该方法用于识别在现有技术中建议的所有潜在参数中指示对5-氟尿嘧啶(5-FU)和/或5-FU类似物敏感的参数,以及确定在什么条件下参数可提供最高的特异性。

解决方案:确定患有癌症的患者是否对5-FU和/或5-FU类似物治疗敏感的方法包括(a)测定临床样品中的胸苷磷酸化酶(TP)mRA表达,(b)测定临床样品中的二氢嘧啶脱氢酶(DPD)mRNA表达,(c)确定步骤(a)中获得的值与步骤(b)中获得的值之比,以及(d)是否步骤(c)中获得的比率超过预定的截止值。

版权:(C)2005,JPO&NCIPI

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号